Creative Medical Technology Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by Creative Medical Technology Holdings, Inc., a Nevada corporation, with a report date of April 26, 2018. The document discloses unregistered sales of equity securities. The registrant is identified as an emerging growth company.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial disclosure relates to capital structure changes through equity issuance.
Material Changes
The company reported significant changes to its outstanding share count resulting from conversions and exercises occurring between August 15, 2018, and August 29, 2018:
- Shares Issued via Note Conversion: 27,104,977 shares.
- Shares Issued via Cashless Warrant Exercise: 40,540,985 shares.
- Total Shares Issued in Period: 67,645,962 shares.
- Outstanding Common Stock: 784,794,117 shares as of April 27, 2018.
Note: There is a chronological discrepancy in the source text where the reported events (August 2018) and signature date (August 31, 2018) occur after the stated report date (April 26, 2018).
Guidance, Outlook, and Risks
The filing does not contain management guidance, future outlook, or specific risk factors beyond the disclosure of unregistered securities sales. The issuances were made pursuant to the exemption provided by Section 3(a)(9) of the Securities Act of 1933.
Investor Verification Checklist
- Verify the accuracy of the outstanding share count (784,794,117) given the date discrepancies in the filing.
- Confirm the terms of the outstanding notes and warrants that were converted or exercised.
- Review the company's latest 10-K or 10-Q for financial performance metrics not included in this 8-K.
- Validate the "Emerging Growth Company" status and its implications for financial reporting.